These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 7542410)

  • 1. Therapy of chronic hepatitis due to HCV.
    Orito E; Mizokami M
    Trop Gastroenterol; 1994; 15(4):186-90. PubMed ID: 7542410
    [No Abstract]   [Full Text] [Related]  

  • 2. Virological patterns of hepatitis C virus in chronic hepatitis C with biochemical sustained response to interferon therapy.
    De Mitri MS; Iervese T; Pisi E; Morsica G; Lazzarin A
    Hepatology; 1996 May; 23(5):1287-9. PubMed ID: 8621169
    [No Abstract]   [Full Text] [Related]  

  • 3. Cold activation of complement for monitoring the response to interferon in patients with chronic hepatitis C.
    Akahane Y; Miyazaki Y; Naitoh S; Takeda K; Tsuda F; Okamoto H; Itoh K; Miyakawa Y; Mayumi M
    Am J Gastroenterol; 1996 Feb; 91(2):319-27. PubMed ID: 8607500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Introduction: combination antiviral therapy in chronic hepatitis C.
    Sherlock S
    J Hepatol; 1995; 23 Suppl 2():1-2. PubMed ID: 8720285
    [No Abstract]   [Full Text] [Related]  

  • 5. [Optimal antiviral therapy of chronic hepatitis caused by hepatitis C virus].
    Cooreman MP; Stadhouders P
    Orv Hetil; 1997 Jun; 138(22 Suppl 1):1476-82. PubMed ID: 9221377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapy.
    Zanetti AR; Romanò L; Brunetto M; Colombo M; Bellati G; Tackney C
    J Med Virol; 2003 May; 70(1):27-30. PubMed ID: 12629640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of HCV RNA assays for the detection and quantification of hepatitis C virus RNA levels in serum of patients with chronic hepatitis C treated with interferon.
    Trabaud MA; Bailly F; Si-Ahmed SN; Chevallier P; Sepetjan M; Colucci G; Trépo C
    J Med Virol; 1997 May; 52(1):105-12. PubMed ID: 9131466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Factors related to response to interferon in chronic hepatitis C].
    Pérez Alvarez R
    Gastroenterol Hepatol; 1996 Apr; 19(4):217-23. PubMed ID: 8665363
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intercalation monitoring PCR(IM-PCR), its principle and application: quantitative monitoring of HCV RNA in the course of IFN therapy].
    Ishiguro T; Saitoh J
    Rinsho Byori; 1997 Mar; 45(3):213-7. PubMed ID: 9086823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The natural history of HCV infection: the role of interferon therapy].
    Rumi MG; Romeo R
    Minerva Gastroenterol Dietol; 1995 Mar; 41(1):119-22. PubMed ID: 7542482
    [No Abstract]   [Full Text] [Related]  

  • 11. Mathematicians turn their attention to hepatitis C.
    Blower S; Ganem D
    Nat Med; 1998 Nov; 4(11):1233-4. PubMed ID: 9809538
    [No Abstract]   [Full Text] [Related]  

  • 12. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C.
    Martinot-Peignoux M; Marcellin P; Pouteau M; Castelnau C; Boyer N; Poliquin M; Degott C; Descombes I; Le Breton V; Milotova V
    Hepatology; 1995 Oct; 22(4 Pt 1):1050-6. PubMed ID: 7557850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection.
    Lehmann M; Meyer MF; Monazahian M; Tillmann HL; Manns MP; Wedemeyer H
    J Med Virol; 2004 Jul; 73(3):387-91. PubMed ID: 15170633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C and G co-infection: response to interferon therapy and quantitative changes in serum HGV-RNA.
    McHutchison JG; Nainan OV; Alter MJ; Sedghi-Vaziri A; Detmer J; Collins M; Kolberg J
    Hepatology; 1997 Nov; 26(5):1322-7. PubMed ID: 9362379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Future therapies for hepatitis C.
    Pawlotsky JM; Gish RG
    Antivir Ther; 2006; 11(4):397-408. PubMed ID: 16856613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon therapy in chronic viral hepatitis.
    Guptan RC; Sarin SK
    J Assoc Physicians India; 1995; Suppl 3():44-51. PubMed ID: 8773122
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative evaluation of hepatitis C virus RNA quantitation by branched DNA, NASBA, and monitor assays.
    Lunel F; Cresta P; Vitour D; Payan C; Dumont B; Frangeul L; Reboul D; Brault C; Piette JC; Huraux JM
    Hepatology; 1999 Feb; 29(2):528-35. PubMed ID: 9918931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence.
    Sharma P; Marrero JA; Fontana RJ; Greenson JK; Conjeevaram H; Su GL; Askari F; Sullivan P; Lok AS
    Liver Transpl; 2007 Aug; 13(8):1100-8. PubMed ID: 17377914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis C virus infection].
    Chayama K; Kumada H
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):55-8. PubMed ID: 10088336
    [No Abstract]   [Full Text] [Related]  

  • 20. Genome detection in liver and peripheral blood mononuclear cells: predictor factors of sustained response in patients with chronic hepatitis C.
    Berenguer M; Olaso V; Córdoba J; Gobernado M; Carrasco D; Berenguer J
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):899-903. PubMed ID: 8574725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.